Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models
Journal of Clinical Investigation · 15.11.2024 · 134 (22)
DOI: 10.1172/jci181111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 19.09.2024. Verfasst von Alison C Livada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Aab Cardiovascular Research Institute. Hauptthemen laut MEDLINE: Megakaryocytes, Thrombocytopenia, Blood Platelets, Lung. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, University Award, University of Rochester.
Abstract (Originalsprache)
Lung megakaryocytes (Mks) are largely extravascular with an immune phenotype (1). Because bone marrow (BM) Mks are short lived, it has been assumed that extravascular lung Mks are constantly “seeded” from the BM. To investigate lung Mk origins and how origin affects their functions, we developed methods to specifically label lung Mks using CFSE dye and biotin delivered via the oropharyngeal route. Labeled lung Mks were present for up to 4 months, while BM Mks had a lifespan of less than 1 week. In a parabiosis model, lung Mks were partially replaced over 1 month from a circulating source. Unlike tissue-resident macrophages, using MDS1 -Cre-ERT2 TdTomato mice, we found that lung Mks arose from hematopoietic stem cells. However, studies with FlkSwitch mTmG mice showed that lung Mks were derived from a Flt3-independent lineage that did not go through a multipotent progenitor. CFSE labeling to track lung Mk–derived platelets showed that approximately 10% of circulating platelets were derived from lung-resident Mks at steady state, but in sterile thrombocytopenia this was doubled (~20%). Lung-derived platelets were similarly increased in a malaria infection model ( Plasmodium yoelii ) typified by thrombocytopenia. These studies indicate that lung Mks arise from a Flt3 – BM source, are long-lived, and contribute more platelets during thrombocytopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aab Cardiovascular Research Institute.
- Department of Pathology and Laboratory Medicine.
- Department of Pediatrics.
- Department of Comparative Medicine.
- Department of Microbiology and Immunology, and.
- Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- University Award, University of Rochester
- a
Zitieren
APA
Livada, A. C., McGrath, K. E., Malloy, M. W., Li, C., Ture, S. K., Kingsley, P. D., Koniski, A. D., Vit, L. A., Nolan, K. E., Mickelsen, D., Monette, G. E., Maurya, P., Palis, J., & Morrell, C. N. (2024). Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models. Journal of Clinical Investigation, 134(22). https://doi.org/10.1172/jci181111
Vancouver
Livada AC, McGrath KE, Malloy MW, Li C, Ture SK, Kingsley PD, et al. Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models. Journal of Clinical Investigation. 2024;134(22). doi:10.1172/jci181111
BibTeX
@article{Livada2024,
author = {Livada, Alison C and McGrath, Kathleen E and Malloy, Michael W and Li, Chen and Ture, Sara K and Kingsley, Paul D and Koniski, Anne D and Vit, Leah A and Nolan, Katherine E and Mickelsen, Deanne and Monette, Grace E and Maurya, Preeti and Palis, James and Morrell, Craig N},
title = {Long-lived lung megakaryocytes contribute to platelet recovery in thrombocytopenia models},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {22},
doi = {10.1172/jci181111}
}
EUVIMED